Browse By Region

Browse By Category
Recent News
By Category: Countermeasures
Paragon Bioservices announces contract for Marburg vaccine
Paragon Bioservices announced this week that it has been awarded $4.99 million dollars by the U.S. Army to assist the USAMRIID in developing vaccines against such diseases as Ebola Sudan, Ebola Zaire and Marburg virus. These viruses are considered bioterror threats as they can be spread through aerosol methods. The Marburg and Ebola viruses are Read More »
- October 22, 2010
- | Filed under Countermeasures
Israel building underground facility in case of biotteror attacks
Officials with Israel's Rambam medical center in Haifa say they are taking part in a massive project to fortify the center against a direct conventional, biological or chemical attack. Professor Karl Skorecki, director of medical and research development at the center, told Xinhuanet.com that the 1,000 bed hospital came under several Katyusha rocket attacks by Read More »
- October 19, 2010
- | Filed under Countermeasures
BioWatch system faces technical, operational challenges
In 2003 U.S. authorities set up a network of air samplers in major cities designed quickly to detect biological agents released in a terrorist attacks; new report says that the system, known as BioWatch, faces “serious technical and operational challenges”
- October 15, 2010
- | Filed under North America and Countermeasures
HHS Seeks to Deter Creation of Synthetic Pathogens
The U.S. Health and Human Services Department yesterday issued advice to help companies that sell synthetic gene sequences prevent their products from being used to produce biological weapons, the Center for Infectious Disease Research and Policy reported yesterday (see GSN, Sept. 10). (Oct. 14) – Model DNA strands on display at a museum in London, Read More »
- October 14, 2010
- | Filed under North America, Biosafety, and Countermeasures
NIH Funds Advanced Development of 3 Biodefense Vaccines
NIH funds advanced development of 3 biodefense vaccinesWebnewswire.com (press release)… says Michael G. Kurilla, MD, Ph.D., director of the Office of Biodefense Research Affairs in NIAIDs Division of Microbiology and Infectious Diseases. …
- October 10, 2010
- | Filed under North America, Biotechnology, Countermeasures, and Public Health